[HTML][HTML] Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried, I Sofer… - Nature …, 2020 - nature.com
ABSTRACT HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially
single-shot alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot
alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried… - Nature …, 2020 - ui.adsabs.harvard.edu
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot
alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion.

AD Nahmad, Y Raviv, M Horovitz-Fried… - Nature …, 2020 - search.ebscohost.com
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot
alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried… - Nature …, 2020 - ideas.repec.org
ABSTRACT HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially
single-shot alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried, I Sofer… - Nature …, 2020 - cris.bgu.ac.il
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot
alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing …

[HTML][HTML] Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried… - Nature …, 2020 - ncbi.nlm.nih.gov
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot
alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion.

AD Nahmad, Y Raviv, M Horovitz-Fried… - Nature …, 2020 - europepmc.org
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot
alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried… - Nature …, 2020 - econpapers.repec.org
ABSTRACT HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially
single-shot alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly …